MedPath

CHEMBIO DIAGNOSTIC SYSTEMS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Performance of Chembio's DPP(R) Syphilis Screen & Confirm Rapid Test System

Withdrawn
Conditions
Syphilis
First Posted Date
2012-03-02
Last Posted Date
2015-07-29
Lead Sponsor
Chembio Diagnostic Systems, Inc.
Registration Number
NCT01543295
Locations
🇺🇸

Mattel Childrens Hospital, University of California, David Geffen School of Medicine, Los Angeles, California, United States

🇺🇸

Therafirst Medical Center, Fort Lauderdale, Florida, United States

🇺🇸

University of Maryland, Baltimore, Maryland, United States

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

Completed
Conditions
HIV Infections
Interventions
Device: In Vitro Diagnostic Device
First Posted Date
2009-12-16
Last Posted Date
2012-04-30
Lead Sponsor
Chembio Diagnostic Systems, Inc.
Target Recruit Count
2808
Registration Number
NCT01032902
Locations
🇺🇸

University of Texas HSC, Houston, Texas, United States

🇺🇸

Univeristy of California, San Diego, La Jolla, California, United States

🇺🇸

University of Maryland, Baltimore, Maryland, United States

and more 2 locations

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

Completed
Conditions
HIV Infections
First Posted Date
2008-03-14
Last Posted Date
2015-08-17
Lead Sponsor
Chembio Diagnostic Systems, Inc.
Target Recruit Count
101
Registration Number
NCT00636220
Locations
🇺🇸

Evelyn Jordan Center, University of Maryland, Baltimore, Maryland, United States

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

Completed
Conditions
HIV Infections
First Posted Date
2007-12-05
Last Posted Date
2008-06-27
Lead Sponsor
Chembio Diagnostic Systems, Inc.
Target Recruit Count
10
Registration Number
NCT00567749
Locations
🇺🇸

Laboratory of Viral Diagnostics, University of Maryland School of Medicine, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath